Christina Furebring
Chief Operating Officer at Strike Pharma AB
Profile
Christina Furebring is currently the Deputy Director at Atlas Therapeutics AB and A Bioscience Incentive AB.
She is also the Chief Operations Officer at Strike Pharma AB since 2022.
Previously, she worked as the Senior Vice President-Preclinical Development at Alligator Bioscience AB.
Dr. Furebring holds a doctorate degree from the University of Lund.
Christina Furebring active positions
| Companies | Position | Start |
|---|---|---|
| A Bioscience Incentive AB | Corporate Officer/Principal | - |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The private company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Corporate Officer/Principal | - |
Strike Pharma AB
 Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Chief Operating Officer | 2021-12-31 |
Former positions of Christina Furebring
| Companies | Position | End |
|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Corporate Officer/Principal | - |
Training of Christina Furebring
| University of Lund | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ALLIGATOR BIOSCIENCE AB | Health Technology |
| Private companies | 3 |
|---|---|
Atlas Therapeutics AB
Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The private company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Health Technology |
| A Bioscience Incentive AB | |
Strike Pharma AB
Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Commercial Services |
- Stock Market
- Insiders
- Christina Furebring
